Annals of Hematology

, Volume 93, Issue 6, pp 1075–1076 | Cite as

Hepatitis B virus reactivation associated with ruxolitinib

  • Chien-Heng Shen
  • Cih-En Hwang
  • Yi-Yang Chen
  • Chih-Cheng Chen
Letter to the Editor

Notes

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Harrison C, Kiladjian JJ, Al-Ali HK et al (2012) JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis. N Engl J Med 366:787–798PubMedCrossRefGoogle Scholar
  2. 2.
    Verstovsek S, Mesa RA, Gotlib J et al (2012) A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis. N Engl J Med 366:799–807PubMedCrossRefGoogle Scholar
  3. 3.
    O’Shea JJ, Holland SM, Staudt LM (2013) JAKs and STATs in immunity, immunodeficiency, and cancer. N Engl J Med 368:161–170PubMedCrossRefGoogle Scholar
  4. 4.
    Kontzias A, Kotlyar A, Laurence A et al (2012) Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease. Curr Opin Pharmacol 12:464–470PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Tefferi A (2012) JAK inhibitors for myeloproliferative neoplasms: clarifying facts from myths. Blood 119:2721–2730PubMedCrossRefGoogle Scholar
  6. 6.
    Wathes R, Moule S, Milojkovic D (2013) Progressive multifocal leukoencephalopathy associated with ruxolitinib. N Engl J Med 369:197–198PubMedCrossRefGoogle Scholar
  7. 7.
    Goldberg RA, Reichel E, Oshry LJ (2013) Bilateral toxoplasmosis retinitis associated with ruxolitinib. N Engl J Med 369:681–683PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Chien-Heng Shen
    • 1
    • 3
  • Cih-En Hwang
    • 2
  • Yi-Yang Chen
    • 2
  • Chih-Cheng Chen
    • 2
    • 3
  1. 1.Division of Gastroenterology, Department of MedicineChang Gung Memorial Hospital-ChiayiChiayiRepublic of China
  2. 2.Division of Hematology Oncology, Department of MedicineChang Gung Memorial Hospital-ChiayiChiayiRepublic of China
  3. 3.Graduate Institute of Clinical Medical SciencesCollege of Medicine, Chang Gung UniversityTao-YuanRepublic of China

Personalised recommendations